PreveCeutical Announ
PreveCeutical Announces Appointment of Dr. Maher Khaled as Director of International Operations
26 févr. 2018 09h30 HE | PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Feb. 26, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE: PREV)(OTCQB:PRVCF)(FSE:18H), announces the...
PreveCeutical Signs
PreveCeutical Signs Research and Option Agreement with UniQuest Pty Limited for Development of Non-Addictive Analgesic Peptides
30 janv. 2018 09h30 HE | PreveCeutical Medical Inc.
VANCOUVER, British Columbia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces that,...
ATI Physical Therapy: Healthcare Experts Discuss Alternatives to the Opioid Crisis
29 janv. 2018 17h14 HE | ATI Physical Therapy
Bolingbrook, Ill., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Experts from cross-sections of the U.S. healthcare industry met on January 26th in Chicago at the ATI Forum: Opioid Edition, Presented by ATI...
Veritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial Facility
29 déc. 2017 03h05 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces that it has completed a prestudy...
US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert
28 nov. 2017 03h05 HE | Veritas Pharma Inc.
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) announces its research arm, Cannevert...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
20 sept. 2017 08h37 HE | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that it has filed an Abbreviated New Drug Application (ANDA) with...
24 août 2017 08h00 HE | Grantmakers In Aging
Washington, DC, Aug. 24, 2017 (GLOBE NEWSWIRE) -- The opioid crisis is a story of many types of pain, and how individuals, families, and entire communities – particularly small and rural ones – are...
Trevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain Medications
20 juin 2017 16h01 HE | Trevena Inc.
KING OF PRUSSIA, Pa., June 20, 2017 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced its recent participation in the “Cutting Edge Science Meeting Series to End the Opioid Crisis:...
BioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDA
28 nov. 2016 06h00 HE | BioCorRx
ANAHEIM, CA, Nov. 28, 2016 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTC PINK: BICX) (the "Company"), a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions,...
Issue Brief Explores the Many Facets of Opioid Abuse
14 sept. 2016 07h33 HE | The Center for Health Affairs
CLEVELAND, Sept. 14, 2016 (GLOBE NEWSWIRE) -- The Center for Health Affairs' August 2016 Issue Brief, A Growing Epidemic: Battling Opioid Abuse in Ohio, explores the many facets of the opioid abuse...